Phase 2 Schizophrenia Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been formally diagnosed with schizophrenia as their primary psychiatric condition
• People whose schizophrenia has been in a stable, non-crisis phase for at least 8 weeks before the screening appointment, as judged by the study doctor
• People who have had a schizophrenia diagnosis for at least 1 year before the screening appointment
• People who have been taking a single antipsychotic medication (with any additional mental health medications) at the same stable dose for at least 2 months before screening
• People aged between 18 and 55 years old (male or female)
• People whose body weight falls within a healthy range, specifically a Body Mass Index (BMI) between 18 and 40 (confirm with trial site if unsure how to calculate this)
• People who the study doctor believes are able to follow all study procedures throughout the trial
• People who have read, understood, and signed a consent form before the screening process begins

Who may not be able to join:

• People who are currently being treated with more than one antipsychotic medication at the time of screening
• People who show certain movement-related side effects, measured by a standard rating scale called the Modified Simpson-Angus Scale, scoring 2 or higher on any individual item at screening (confirm with trial site)
• People who have a moderate to severe problem with substance use — this includes alcohol, but does not include nicotine or caffeine
• People who have an unstable or poorly controlled physical health condition

Important: Always verify eligibility with the trial site directly before applying.